A conversation with Dr. Mark Charest about the biotech market.
Why has the marketplace gone up this summer after undergoing its worst drawdown in history? Is this pace sustainable? What to look for and what to stay away from? Are there headwinds? Tailwinds?
Dr. Charest has many interest things worth hearing:
댓글